Edition:
United States

DarioHealth Corp (DRIO.OQ)

DRIO.OQ on NASDAQ Stock Exchange Capital Market

0.98USD
20 Sep 2018
Change (% chg)

-- (--)
Prev Close
$0.98
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
12,729
52-wk High
$3.64
52-wk Low
$0.92

Chart for

About

DarioHealth Corp, formerly Labstyle Innovations Corp, is a digital health (mHealth) company. The Company is engaged in developing and commercializing a technology providing consumers with laboratory-testing capabilities using smart phones and other mobile devices. The Company's product, Dario, also known as Dario Smart Diabetes... (more)

Overall

Beta: -2.01
Market Cap(Mil.): $22.20
Shares Outstanding(Mil.): 21.34
Dividend: --
Yield (%): --

Financials

  DRIO.OQ Industry Sector
P/E (TTM): -- 39.59 32.65
EPS (TTM): -1.85 -- --
ROI: -583.28 14.14 12.72
ROE: -601.95 17.36 14.84

BRIEF-DarioHealth Corp Reports Quarterly Loss Per Share Of $0.20

* QUARTERLY LOSS PER SHARE $0.20 Source text for Eikon: Further company coverage:

May 15 2018

BRIEF-Dariohealth Corp Says Selling Stockholders May Offer From Time To Time Up To 8.5 Mln shares

* DARIOHEALTH CORP SAYS SELLING STOCKHOLDERS MAY OFFER FROM TIME TO TIME UP TO 8.5 MILLION SHARES OF CO'S COMMON STOCK - SEC FILING Source text for Eikon: (http://bit.ly/2Fkuvtb) Further company coverage:

Apr 26 2018

BRIEF-DarioHealth Receives U.S. FDA Clearance For iPhone 7, 8 And iPhone X Smart Glucose Meter

* DARIOHEALTH RECEIVES U.S. FDA CLEARANCE FOR IPHONE 7, 8 AND IPHONE X SMART GLUCOSE METER Source text for Eikon: Further company coverage:

Mar 26 2018

Competitors

Earnings vs. Estimates